| 0 (0%) | 05-08 19:16 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.96 |
1-year : | 1.09 |
| Resists | First : | 0.82 |
Second : | 0.93 |
| Pivot price | 0.75  |
|||
| Supports | First : | 0.64 |
Second : | 0.54 |
| MAs | MA(5) : | 0.84 |
MA(20) : | 0.73 |
| MA(100) : | 0.88 |
MA(250) : | 1.22 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 78.8 |
D(3) : | 90.9 |
| RSI | RSI(14): 52.7 |
|||
| 52-week | High : | 2.11 | Low : | 0.61 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ GWH ] has closed below upper band by 41.1%. Bollinger Bands are 35.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.92 - 0.93 | 0.93 - 0.93 |
| Low: | 0.77 - 0.77 | 0.77 - 0.78 |
| Close: | 0.78 - 0.78 | 0.78 - 0.79 |
Mon, 26 Apr 2021
Is GW Pharmaceuticals (NASDAQ:GWPH) A Risky Investment? - Yahoo Finance
Wed, 10 Feb 2021
Jazz Pharmaceuticals to Acquire GW Pharma - Cannabis Industry Journal
Wed, 03 Feb 2021
Jazz Pharmaceuticals to Buy GW Pharmaceuticals (GWPH) for $7.2 Billion - Bloomberg
Wed, 03 Feb 2021
GWPH Stock: 12 Things to Know About the GW Pharma-Jazz Pharma Deal - InvestorPlace
Wed, 03 Feb 2021
GWPH Stock Rockets On $7.2 Billion Jazz Pharma Takeover - Investor's Business Daily
Sun, 24 Jan 2021
GW Pharma Well Placed For Further Progress In 2021 And Beyond (NASDAQ:GWPH-DEFUNCT-99931) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 175 (M) |
| Held by Insiders | 6.537e+007 (%) |
| Held by Institutions | 39.1 (%) |
| Shares Short | 11,860 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -7.939e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -681.9 % |
| Return on Assets (ttm) | -34 % |
| Return on Equity (ttm) | -64.6 % |
| Qtrly Rev. Growth | 17 % |
| Gross Profit (p.s.) | 234.37 |
| Sales Per Share | 4.7125e+006 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -0.5 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -55 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 2.12 |
| Dividend | 0 |
| Forward Dividend | 1.086e+007 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|